Abstract Ischemic stroke remains a leading cause of death and disability, and mitochondrial dysfunction links bioenergetic failure, oxidative stress, neuroinflammation, blood–brain barrier (BBB) injury, and cell death. Despite extensive preclinical neuroprotection research, translation has often failed because candidat...
Ye-Wu Ding, Xiu-Fei Teng, Ting-Yi Guo et al.· International Journal of Nan...· 0 citations
Findings indicate that TZ may protect against CIRI by suppressing apoptosis and neuroinflammation through activation of the PI3K/AKT/mTOR signaling pathway, thereby providing preclinical evidence for its potential repurposing as a treatment for ischemic stroke.
Lin-Lin Xie, Yu-Kun Ping, Jie Zhao et al.· Current Neuropharmacology· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.